(KJAN) Innovator Russell 2000 - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • • Defined Outcome
KJAN: Stocks, Options, Index Funds
The Innovator Russell 2000 Power Buffer ETF January (BATS: KJAN) is designed to provide investors with exposure to the Russell 2000 Index while incorporating a buffer against potential losses. The fund achieves this by investing at least 80% of its net assets in FLEX Options, which are highly customizable exchange-traded options contracts. These options are tied to the performance of the iShares Russell 2000 ETF, an underlying ETF that tracks the Russell 2000 Index. The Russell 2000 Index is a float-adjusted, capitalization-weighted index of equity securities issued by the approximately 2,000 smallest companies in the Russell 3000 Index, offering a benchmark for small-cap U.S. equities. The ETF is non-diversified, meaning it may concentrate its investments in a smaller number of securities.
KJAN is part of the Defined Outcome ETF category, focusing on delivering specific risk-return profiles. It is listed on the BATS exchange under the ticker symbol KJAN and is registered in the United States. The funds structure is designed to appeal to investors seeking buffered exposure to small-cap equities, combining the benefits of options-based strategies with the transparency of an ETF wrapper.
Based on the provided data, KJAN shows a recent price of $37.07 with an average 20-day volume of 28,963 shares. The funds moving averages indicate a short-term SMA of $37.79, a mid-term SMA of $37.81, and a long-term SMA of $36.86. The Average True Range (ATR) of 0.35 suggests relatively low volatility. With assets under management (AUM) of $353.58 million, KJAN is a moderately sized ETF within its category.
Over the next three months, KJAN is expected to trade within a narrow range, influenced by the performance of the Russell 2000 Index and the options strategies employed. The SMA crossover suggests a neutral to slightly bearish outlook, as the SMA 20 ($37.79) is above the SMA 50 ($37.81) but slightly above the SMA 200 ($36.86). The ATR of 0.35 indicates that price fluctuations are likely to remain subdued, with potential resistance near $38.00 and support near $36.50. The funds AUM of $353.58 million reflects moderate investor interest, which may stabilize liquidity but could also limit upward momentum in the near term.
Additional Sources for KJAN ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
KJAN ETF Overview
Market Cap in USD | 333m |
Category | Defined Outcome |
TER | 0.79% |
IPO / Inception | 2019-12-31 |
KJAN ETF Ratings
Growth 5y | 73.1% |
Fundamental | - |
Dividend | 0.0% |
Rel. Strength Industry | -6.16 |
Analysts | - |
Fair Price Momentum | 32.63 USD |
Fair Price DCF | - |
KJAN Dividends
No Dividends PaidKJAN Growth Ratios
Growth Correlation 3m | -50% |
Growth Correlation 12m | 82.8% |
Growth Correlation 5y | 81% |
CAGR 5y | 11.26% |
CAGR/Max DD 5y | 0.74 |
Sharpe Ratio 12m | 0.71 |
Alpha | -5.53 |
Beta | 0.72 |
Volatility | 14.54% |
Current Volume | 364k |
Average Volume 20d | 17.7k |
As of March 14, 2025, the stock is trading at USD 35.47 with a total of 363,950 shares traded.
Over the past week, the price has changed by -1.96%, over one month by -6.58%, over three months by -9.07% and over the past year by +1.58%.
Yes. Based on ValueRay Analyses, Innovator Russell 2000 (BATS:KJAN) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 73.08 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of KJAN as of March 2025 is 32.63. This means that KJAN is currently overvalued and has a potential downside of -8.01%.
Innovator Russell 2000 has no consensus analysts rating.
According to ValueRays Forecast Model, KJAN Innovator Russell 2000 will be worth about 36 in March 2026. The stock is currently trading at 35.47. This means that the stock has a potential upside of +1.49%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 36 | 1.5% |